JPRN-UMIN000005309
Completed
未知
A double-blind, randomized controlled pilot study of olive leaf extracts(OLE) for the prevention of periodontal diseases. - Pilot study of OLE for the prevention of periodontal diseases.
Department of Preventive Dentistry, Osaka University Graduate School of Dentistry0 sites45 target enrollmentMarch 25, 2011
ConditionsPeriodontal diseases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Periodontal diseases
- Sponsor
- Department of Preventive Dentistry, Osaka University Graduate School of Dentistry
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Those who took periodontal surgical therapy within 6 months Those who are pregnant or lactating Those who have a history of systematic diseases Those who took antibiotics within 3 months Those who took anti\-inflammatory drugs within 2 weeks Those who have unrestored caries Those who smoke within 6 months Those who participate in other clinical trial Those who are judged not eligible for the study subjects by their investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Do bisphosphonate tablets improve bone health in patients on dialysisEnd Stage Kidney Diseasefracture riskRenal and Urogenital - Kidney diseaseMusculoskeletal - OsteoporosisACTRN12620000321943Westmead Hospital Research and Education Network114
Recruiting
Not Applicable
The distribution and duration of the sensory block after a standard and refined ultrasound guided transversus abdominis plane (TAP) block.ACTRN12610000094077Dr Phillip Cowlishaw20
Recruiting
Not Applicable
A double-blind, randomized controlled trial study on the preventive effect of cetylpyridinium chloride containing mouthwash on gingivitis during orthodontic treatmentgingivitisJPRN-UMIN000051198Ministry of Education, Culture, Sports, Science and Technology60
Active, not recruiting
Not Applicable
A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) - NAThis study aims to assess the safety of PSD506 in men with benign prostatic enlargement (BPE) / benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) and an IPSS of 8-19, in line with Americian Association recommendations.MedDRA version: 8.1Level: LLTClassification code 10055026Term: Prostatic obstructionEUCTR2006-002055-32-DEPlethora Solutions Limited80
Active, not recruiting
Phase 1
A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) - PSD506-OAB-004benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS)MedDRA version: 8.1 Level: LLT Classification code 10055026 Term: Prostatic obstructionEUCTR2006-002055-32-IEPlethora Solutions Limited80